Ocular Therapeutix (OCUL) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$737.1 million.
- Ocular Therapeutix's Enterprise Value fell 8797.66% to -$737.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$737.1 million, marking a year-over-year decrease of 8797.66%. This contributed to the annual value of -$737.1 million for FY2025, which is 8797.66% down from last year.
- Per Ocular Therapeutix's latest filing, its Enterprise Value stood at -$737.1 million for Q4 2025, which was down 8797.66% from -$344.8 million recorded in Q3 2025.
- Ocular Therapeutix's 5-year Enterprise Value high stood at -$66.6 million for Q2 2023, and its period low was -$737.1 million during Q4 2025.
- In the last 5 years, Ocular Therapeutix's Enterprise Value had a median value of -$193.9 million in 2021 and averaged -$264.2 million.
- Per our database at Business Quant, Ocular Therapeutix's Enterprise Value surged by 5049.32% in 2023 and then crashed by 59016.3% in 2024.
- Over the past 5 years, Ocular Therapeutix's Enterprise Value (Quarter) stood at -$164.2 million in 2021, then surged by 37.68% to -$102.3 million in 2022, then plummeted by 91.55% to -$196.0 million in 2023, then plummeted by 100.1% to -$392.1 million in 2024, then tumbled by 87.98% to -$737.1 million in 2025.
- Its Enterprise Value stands at -$737.1 million for Q4 2025, versus -$344.8 million for Q3 2025 and -$391.1 million for Q2 2025.